© 1995 Oxford University Press
research-article |
Escherichia coli lacZ strains engineered for detection of frameshift mutations induced by aromatic amines and nitroaromatic compounds
Guelph-Waterloo Centre for Graduate Work in Chemistry, Department of Chemistry and Biochemistry, University of Guelph Guelph, Ontario NIG 2W1, Canada
1Department of Microbiology, University of Konstanz Konstanz, Germany
2To whom correspondence should be addressed
Escherichia coli lacZ strains CC107-CC111, which detect specific frameshift mutations, were used to study the mutational specificities of 2-nitro-3-methylimidazo[4,5-f]quinoline (NO2-IQ) and rat hepatic S9-activated 2-amino-3-methylimidazo[4,5-f]quinoline (IQ). New constructs were made in which UvrABC-dependent excision repair was eliminated (strains DJ3107-DJ3111), followed by introduction of plasmid pYG219 conferring acetyl CoA:arylamine N-acetyltransferase/acetyl CoA:arylhydroxylamine O-acetyltransferase (NAT/OAT) activity (strains DJ3207-DJ3211). Sensitivity to mutagens was greatly enhanced. The mutational specificity of NO2-IQ was identical to that of the corresponding amine, IQ. The most prominent mutations caused by the two compounds were
and
frameshifts.
Frameshifts play a minor role in the pattern of mutational specificity. Induction of all three mutations was similarly influenced by NAT/OAT activation and UvrABC-dependent excision repair. These new tester strains provide an effective tool for the study of aromatic amine mutational specificity and the influences of excision repair and NAT/OAT activation.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
T. Ohta, M. Watanabe-Akanuma, and H. Yamagata A comparison of mutation spectra detected by the Escherichia coli Lac+ reversion assay and the Salmonella typhimurium His+ reversion assay Mutagenesis, July 1, 2000; 15(4): 317 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A.M. Bol, J. Horlbeck, J. Markovic, J. G. de Boer, R. J. Turesky, and A. Constable Mutational analysis of the liver, colon and kidney of Big Blue(R) rats treated with 2-amino-3-methylimidazo[4,5-f]quinoline Carcinogenesis, January 1, 2000; 21(1): 1 - 6. [Abstract] [Full Text] [PDF] |
||||

